Clinical Trial Update: L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating adding L-methylfolate to OROS-methylphenidate in adults with ADHD has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Concerta (methylphenidate, OROS system) (methylphenidate)
• L-methylfolate (L-methylfolate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-11-14